Fact CheckerSign in

NCT07233941Recruiting

Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal phase of the migraine attack; pharmacological therapy; and detoxification treatment in patients with migraine associated with medication overuse headache.

Status (registry)
Recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
14 Nov 2025
Start date
1 Sept 2025
Primary completion date
May 2027
Lead sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Diseases
Migraine
NCT number
NCT07233941

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 1 Sept 2025 to the primary completion date, May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Severe medical or psychiatric conditions (depression, schizophrenia, psychosis) documented by specific previous diagnoses.

Other illness

  • A history of alcohol or drug abuse.

Other

  • Primary sensory deficits.

Who the study is looking for

  • Written informed consent.
  • Patients aged between 18 and 65 years.
  • Diagnosis of migraine according to the International Classification of Headache Disorders (ICHD-3) criteria.
  • Patients with a history of migraine for at least one year, to ensure the stability of the condition.
  • Stability of ongoing treatment for at least 3 months at baseline.
  • Understanding of the Italian language.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS Istituto Neurologico Carlo Besta
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.